IMMUNOGEN

Serial Number 87831665
Registration 6075454
700

Registration Progress

Application Filed
Mar 13, 2018
Under Examination
Apr 16, 2019
Approved for Publication
Feb 19, 2019
Published for Opposition
Feb 19, 2019
Registered
Jun 9, 2020

Attorney Assistance

Section 8 (6-Year) Declaration Due (Based on registration date 2020-06-09)
Due: Jun 09, 2026 327 days

Trademark Image

IMMUNOGEN

Basic Information

Serial Number
87831665
Registration Number
6075454
Filing Date
March 13, 2018
Registration Date
June 9, 2020
Published for Opposition
February 19, 2019
Drawing Code
3

Status Summary

Current Status
Active
Status Code
700
Status Date
Jun 9, 2020
Registration
Registered
Classes
005

Rights Holder

ImmunoGen, Inc.

03
Address
830 Winter Street
Waltham, MA 02451

Ownership History

ImmunoGen, Inc.

Original Applicant
03
Waltham, MA

ImmunoGen, Inc.

Owner at Publication
03
Waltham, MA

ImmunoGen, Inc.

Original Registrant
03
Waltham, MA

Legal Representation

Attorney
Jenevieve J. Maerker, Esq.

USPTO Deadlines

Next Deadline
327 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2020-06-09)
Due Date
June 09, 2026
Grace Period Ends
December 09, 2026
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

27 events
Date Code Type Description Documents
Jun 9, 2025 REM1 E COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Loading...
Jun 9, 2020 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
May 2, 2020 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
May 1, 2020 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Apr 29, 2020 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Apr 29, 2020 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Apr 14, 2020 IUAF S USE AMENDMENT FILED Loading...
Apr 14, 2020 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Oct 3, 2019 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Oct 1, 2019 EX1G S SOU EXTENSION 1 GRANTED Loading...
Oct 1, 2019 EXT1 S SOU EXTENSION 1 FILED Loading...
Oct 1, 2019 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Apr 16, 2019 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Feb 19, 2019 PUBO A PUBLISHED FOR OPPOSITION Loading...
Feb 19, 2019 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jan 30, 2019 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Dec 19, 2018 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Dec 18, 2018 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Dec 18, 2018 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Dec 18, 2018 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jun 18, 2018 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jun 18, 2018 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jun 18, 2018 GNRT F NON-FINAL ACTION E-MAILED Loading...
Jun 12, 2018 DOCK D ASSIGNED TO EXAMINER Loading...
Mar 21, 2018 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Mar 20, 2018 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Mar 16, 2018 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
House mark for pharmaceutical products for human use, namely, pharmaceutical preparations for treatment of cancer; house mark for pharmaceutical products for human use, namely, pharmaceutical preparations for treatment of oncological diseases, disorders, and conditions
First Use Anywhere: Dec 19, 2019
First Use in Commerce: Dec 19, 2019

Additional Information

Design Mark
The mark consists of the word IMMUNOGEN in stylized form, with the letter "O" created by negative space against the neighboring letters and the dot in the middle of the letter "O" displayed in a contrasting shade.
Color Claim
Color is not claimed as a feature of the mark.

Classification

International Classes
005